Advertisement
Advertisement
Trending on Urology Times
1
Comparing Perioperative Strategies in Cisplatin-Eligible MIBC
2
Perioperative Therapy Expansion in Cisplatin-Ineligible MIBC
3
PROTEUS: Apalutamide plus ADT before and after RP cuts metastasis risk
4
Pedro Barata, MD, highlights phase 3 data on 177Lu-rosopatamab tetraxetan in mCRPC
5